NLRP6 and metabolic dysfunction-associated steatotic liver disease: On the one hand, and in contrast to the data described above, Nlrp3-, Nlrp6-, Asc- and caspase-1-deficient mice present with a more severe course of NAFLD/NASH than WT controls [76] (Figure 2, panel 5).